Parkinson's disease: Difference between revisions

No edit summary
No edit summary
Line 14: Line 14:
***Impaired ability to turn or change direction while walking
***Impaired ability to turn or change direction while walking


== Treatment ==
== Treatmenthttp://www.wikem.org/w/index.php?title=Parkinson%27s_Disease&action=edit&section=3 ==


*Anticholinergics  
*Anticholinergics  
**Benztropine  
**Benztropine  
*Dopamine agonists  
*Dopamine agonists  
**Levodopa  
**Levodopa/ Carbidopa<br>
**pramipexole (Mirapex) <br>ropinirole (Requip)<br>
*Monoamine oxidase inhibitor - blocks DA reuptake<br>
**selegiline (Eldepryl)<br>
**rasagiline (Azilect)<br>
**Bromocriptine
**Bromocriptine


Revision as of 19:51, 5 November 2012

Background

  • Extrapyramidal movement disorder a/w reduced dopaminergic receptors in substantia nigra

Clinical Features

  • TRAP mnemonic:
    • Tremor (resting)
      • Initially is unilateral tremor of upper extremity, esp finger and thumb ("pill rolling")
      • Dissipates when intentional movement is performed
    • Rigidity (cogwheel)
      • Elicited by causing passive movement of limb through full range of motion
    • Akinesia
      • Slowness of voluntary movement
    • Posture/equilibrium impairment
      • Impaired ability to turn or change direction while walking

Treatmenthttp://www.wikem.org/w/index.php?title=Parkinson%27s_Disease&action=edit&section=3

  • Anticholinergics
    • Benztropine
  • Dopamine agonists
    • Levodopa/ Carbidopa
    • pramipexole (Mirapex)
      ropinirole (Requip)
  • Monoamine oxidase inhibitor - blocks DA reuptake
    • selegiline (Eldepryl)
    • rasagiline (Azilect)
    • Bromocriptine

Source

Tintinalli

Retrieved from "https://www.wikem.org/w/index.php?title=Parkinson%27s_disease&oldid=10520"